PAPILLOMAVIRUS VACCINE COMPOSITIONS

PAPILLOMAVIRUS VACCINE COMPOSITIONS

PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising virus-like particles (VLPs) of human papillomavirus (HPV), said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid.SOLUTION: The aluminum adjuvant comprises am...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MCCLEMENTS WILLIAM L, CASIMIRO DANILO, BRYAN JANINE T, BROWNLOW MICHELLE K, HU BINGHUA, MEYER BRIAN K, SHI LI
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MCCLEMENTS WILLIAM L
CASIMIRO DANILO
BRYAN JANINE T
BROWNLOW MICHELLE K
HU BINGHUA
MEYER BRIAN K
SHI LI
description PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising virus-like particles (VLPs) of human papillomavirus (HPV), said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid.SOLUTION: The aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect provides multi-dose HPV vaccine formulations, the formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of m-cresol, phenol, and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2014062117A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2014062117A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2014062117A3</originalsourceid><addsrcrecordid>eNrjZFAOcAzw9PHx93UM8wwKDVYIc3R29vRzVXD29w3wD_YM8fT3C-ZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhiYGZkaGhuaOxkQpAgDKXCOG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PAPILLOMAVIRUS VACCINE COMPOSITIONS</title><source>esp@cenet</source><creator>MCCLEMENTS WILLIAM L ; CASIMIRO DANILO ; BRYAN JANINE T ; BROWNLOW MICHELLE K ; HU BINGHUA ; MEYER BRIAN K ; SHI LI</creator><creatorcontrib>MCCLEMENTS WILLIAM L ; CASIMIRO DANILO ; BRYAN JANINE T ; BROWNLOW MICHELLE K ; HU BINGHUA ; MEYER BRIAN K ; SHI LI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising virus-like particles (VLPs) of human papillomavirus (HPV), said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid.SOLUTION: The aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect provides multi-dose HPV vaccine formulations, the formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of m-cresol, phenol, and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140410&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014062117A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140410&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014062117A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCCLEMENTS WILLIAM L</creatorcontrib><creatorcontrib>CASIMIRO DANILO</creatorcontrib><creatorcontrib>BRYAN JANINE T</creatorcontrib><creatorcontrib>BROWNLOW MICHELLE K</creatorcontrib><creatorcontrib>HU BINGHUA</creatorcontrib><creatorcontrib>MEYER BRIAN K</creatorcontrib><creatorcontrib>SHI LI</creatorcontrib><title>PAPILLOMAVIRUS VACCINE COMPOSITIONS</title><description>PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising virus-like particles (VLPs) of human papillomavirus (HPV), said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid.SOLUTION: The aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect provides multi-dose HPV vaccine formulations, the formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of m-cresol, phenol, and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAOcAzw9PHx93UM8wwKDVYIc3R29vRzVXD29w3wD_YM8fT3C-ZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhiYGZkaGhuaOxkQpAgDKXCOG</recordid><startdate>20140410</startdate><enddate>20140410</enddate><creator>MCCLEMENTS WILLIAM L</creator><creator>CASIMIRO DANILO</creator><creator>BRYAN JANINE T</creator><creator>BROWNLOW MICHELLE K</creator><creator>HU BINGHUA</creator><creator>MEYER BRIAN K</creator><creator>SHI LI</creator><scope>EVB</scope></search><sort><creationdate>20140410</creationdate><title>PAPILLOMAVIRUS VACCINE COMPOSITIONS</title><author>MCCLEMENTS WILLIAM L ; CASIMIRO DANILO ; BRYAN JANINE T ; BROWNLOW MICHELLE K ; HU BINGHUA ; MEYER BRIAN K ; SHI LI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2014062117A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MCCLEMENTS WILLIAM L</creatorcontrib><creatorcontrib>CASIMIRO DANILO</creatorcontrib><creatorcontrib>BRYAN JANINE T</creatorcontrib><creatorcontrib>BROWNLOW MICHELLE K</creatorcontrib><creatorcontrib>HU BINGHUA</creatorcontrib><creatorcontrib>MEYER BRIAN K</creatorcontrib><creatorcontrib>SHI LI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCCLEMENTS WILLIAM L</au><au>CASIMIRO DANILO</au><au>BRYAN JANINE T</au><au>BROWNLOW MICHELLE K</au><au>HU BINGHUA</au><au>MEYER BRIAN K</au><au>SHI LI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PAPILLOMAVIRUS VACCINE COMPOSITIONS</title><date>2014-04-10</date><risdate>2014</risdate><abstract>PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising virus-like particles (VLPs) of human papillomavirus (HPV), said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid.SOLUTION: The aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect provides multi-dose HPV vaccine formulations, the formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of m-cresol, phenol, and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2014062117A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PAPILLOMAVIRUS VACCINE COMPOSITIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T14%3A06%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCCLEMENTS%20WILLIAM%20L&rft.date=2014-04-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2014062117A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true